AU2001288058A1 - Means of examining ability of angiogenesis - Google Patents

Means of examining ability of angiogenesis

Info

Publication number
AU2001288058A1
AU2001288058A1 AU2001288058A AU8805801A AU2001288058A1 AU 2001288058 A1 AU2001288058 A1 AU 2001288058A1 AU 2001288058 A AU2001288058 A AU 2001288058A AU 8805801 A AU8805801 A AU 8805801A AU 2001288058 A1 AU2001288058 A1 AU 2001288058A1
Authority
AU
Australia
Prior art keywords
angiogenesis
examining
ability
examining ability
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001288058A
Inventor
Akikuni Yagita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orient Cancer Therapy Co Ltd
Original Assignee
Orient Cancer Therapy Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orient Cancer Therapy Co Ltd filed Critical Orient Cancer Therapy Co Ltd
Publication of AU2001288058A1 publication Critical patent/AU2001288058A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/50—Fibroblast growth factors [FGF]
    • G01N2333/503—Fibroblast growth factors [FGF] basic FGF [bFGF]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/515—Angiogenesic factors; Angiogenin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/71—Assays involving receptors, cell surface antigens or cell surface determinants for growth factors; for growth regulators
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
AU2001288058A 2000-10-11 2001-09-18 Means of examining ability of angiogenesis Abandoned AU2001288058A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2000-310349 2000-10-11
JP2000310349 2000-10-11
JP2001-67473 2001-03-09
JP2001067473 2001-03-09
PCT/JP2001/008098 WO2002031497A1 (en) 2000-10-11 2001-09-18 Means of examining ability of angiogenesis

Publications (1)

Publication Number Publication Date
AU2001288058A1 true AU2001288058A1 (en) 2002-04-22

Family

ID=26601856

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001288058A Abandoned AU2001288058A1 (en) 2000-10-11 2001-09-18 Means of examining ability of angiogenesis

Country Status (3)

Country Link
JP (1) JPWO2002031497A1 (en)
AU (1) AU2001288058A1 (en)
WO (1) WO2002031497A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006304764A1 (en) * 2005-10-21 2007-04-26 Bayer Healthcare Llc Methods for prediction and prognosis of cancer, and monitoring cancer therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10123131A (en) * 1996-10-16 1998-05-15 Toagosei Co Ltd Prognosis examination method
WO1998022616A1 (en) * 1996-11-21 1998-05-28 Kyowa Hakko Kogyo Co., Ltd. ANTI-HUMAN VEGF RECEPTOR F1t-1 MONOCLONAL ANTIBODY
JP3690100B2 (en) * 1998-01-12 2005-08-31 東亞合成株式会社 VEGF / VPF antagonist inhibitor screening method and screening kit

Also Published As

Publication number Publication date
WO2002031497A1 (en) 2002-04-18
JPWO2002031497A1 (en) 2004-02-19

Similar Documents

Publication Publication Date Title
AU2001282467A1 (en) Double sleeve endoscope
AU2001286677A1 (en) Controlled release of substances
AU2001267412A1 (en) Ring fixator
AU8382901A (en) Sanitary fitting
AU2001228848A1 (en) Sanitary ware
EP1195130A3 (en) Endoscope apparatus
AU2001259702A1 (en) Tissue regrafting
AU2001281666A1 (en) Lavatory
AU2001237150A1 (en) Beater
AU2001241837A1 (en) Processed tissue webs
AU3928302A (en) Improved shower apparatus
AU2001239773A1 (en) Baroplastic materials
AU2002222355A1 (en) Slag cement
AU2002230531A1 (en) Use of fgf-19 for inhibiting angiogenesis
AU2371201A (en) Endoscope
AU2002227925A1 (en) Human beta-defensin-3
AU2001271032A1 (en) Means of examining nephropathy
AUPR030800A0 (en) Immunomodulatory preparation
AU2001232041A1 (en) Improved assay
AU2001245950A1 (en) Preparation of deoxynucleosides
AU2001288058A1 (en) Means of examining ability of angiogenesis
AU2001268264A1 (en) Resazurin-based cytotoxicity assay
AU3542101A (en) Sanitary system
AU2001272490A1 (en) Use of galiella lactone
AUPR069500A0 (en) Tissue modification